Jane Street Group, LLC Humanigen, Inc Put Options Transaction History

Jane Street Group, LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 May 17, 2022	BUY	$1.81 - $3.97 $74,934 - $164,358	41,400 Added 37.33%	152,300 $458,000
Q4 2021 Feb 15, 2022	SELL	$3.66 - $8.22 $475,800 - $1.07 Million	-130,000 Reduced 53.96%	110,900 $413,000
Q3 2021 Nov 16, 2021	BUY	$5.93 - $17.83 $76,497 - $230,006	12,900 Added 5.66%	240,900 $1.43 Million
Q2 2021 Aug 16, 2021	BUY	$13.54 - $22.74 $1.27 Million - $2.14 Million	94,100 Added 70.28%	228,000 $3.96 Million
Q1 2021 May 18, 2021	BUY	$12.91 - $23.83 $1.73 Million - $3.19 Million	133,900 New	133,900 $2.56 Million

558K

Ticker HGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,661,000
Description
Humanigen, Inc., a clinical-stage biopharmaceutical company, focuses on preventing and treating an immune hyper-response called ?cytokine storm'. Lenzilumab is an antibody that binds to and neutralizes granulocyte-macrophage colony-stimulating factor (GM-CSF). The company is developing lenzilumab as a treatment for cytokine storm associated with...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.